Glutamic Acid Market Seen Reaching $16.6B by 2030

Allied Market Research says the global glutamic acid market will grow from $9.9 billion in 2020 to $16.6 billion by 2030, driven by demand from food and pharmaceutical uses. Asia-Pacific leads the market now and is expected to post the fastest growth through 2030.

Why it matters: - Glutamic acid demand is rising across food, pharmaceutical, cosmetics and personal care uses, making the market a barometer for several consumer and industrial supply chains. - The projected jump to $16.6 billion by 2030 points to steady long-term growth in ingredients used in processed foods and health-related products. - A stronger preference for natural food additives could open additional growth space for suppliers.

What happened: - Allied Market Research published a report on the global glutamic acid market covering 2021 to 2030. - The market generated $9.9 billion in 2020 and is projected to reach $16.6 billion by 2030. - The report forecasts a 5.4% compound annual growth rate over the period. - The report is titled, “Glutamic Acid Market by End Use Industry (Pharmaceutical, Cosmetics and Personal Care, Food Industry, and others): Global Opportunity Analysis and Industry Forecast, 2021–2030”. - More information is available in the request sample brochure.

The details: - Food industry demand is the main growth driver for the market. - Pharmaceutical demand is also supporting market expansion. - Harmful effects associated with glutamic acid use are a restraint on market growth. - The food industry segment held nearly two-thirds of global market share in 2020. - Glutamic acid is used in soups, snacks, condiments, convenience and functional foods, seasoning blends and noodles. - Processed food represents 80% of worldwide food sales, helping explain the segment’s dominance. - The pharmaceutical segment is projected to grow at a 5.8% CAGR from 2021 to 2030. - Glutamic acid is used in pharmaceuticals for medication related to heart and brain function. - Asia-Pacific, followed by North America, held nearly two-fifths of global revenue in 2020. - Asia-Pacific is expected to post the fastest CAGR at 5.9% during the forecast period. - Industrialization in India and China is increasing demand for glutamic acid. - Rising demand from pharmaceutical and cosmetic and personal care industries is also lifting regional demand. - Higher government spending on the pharmaceutical industry in Asia-Pacific is expected to add further demand. - Leading market players include Amino GmbH, Ajinomoto co, Evonik industries, Fufeng group, Haihang group, Hefei TNJ chemicals, Kyowa Hakko, Medinex, Sichuan Tongsheng amino acid and Wuhan amino acid. - The full report is available here. - Additional release details are available here.

Between the lines: - The market’s growth story is being driven more by staple food applications than by specialty uses. - Asia-Pacific’s lead suggests production and demand are concentrating in fast-industrializing markets rather than mature Western economies. - The fastest-growing pharmaceutical segment may become more important if food additive concerns slow adoption in some channels.

What’s next: - Market growth will likely track demand in processed foods, pharmaceuticals and natural-additive alternatives through 2030. - Asia-Pacific is expected to keep the lead if industrialization and healthcare spending continue at the current pace. - Suppliers will need to balance growth opportunities against safety perceptions tied to glutamic acid use.